Ibio, INC Form 4 insider transactions

Alexandra Kropotova, a director at iBio, Inc., acquired 18,900 stock options on November 21, 2024, according to a recent SEC filing.

Director William D. Clark of iBio, Inc. acquired 18,900 stock options on November 21, 2024, which vest monthly over twelve months.

Director David Arkowitz acquired 12,600 stock options in iBio, Inc. on November 21, 2024.

iBio's Chief Executive Officer and Chief Scientific Officer, Martin Brenner, acquired stock options on May 9, 2024.

Felipe Duran, CFO of iBio, Inc., was granted stock options to purchase 90,000 shares of common stock on May 9, 2024.

Felipe Duran, CFO of iBio, Inc., reports the acquisition of stock options.